Burnstock Geoffrey, Fischer Bilha, Hoyle Charles H V, Maillard Michel, Ziganshin Airat U, Brizzolara Antonia L, von Isakovics Amy, Boyer José L, Harden T Kendall, Jacobson Kenneth A
Department of Anatomy and Developmental Biology, University College London, London, United Kingdom.
Drug Dev Res. 1994 Mar;31(3):206-219. doi: 10.1002/ddr.430310308. Epub 2004 Oct 5.
The structure-activity relationships for a variety of adenine nucleotide analogues at P(2x)- and P(2Y)-purinoceptors were investigated. Compounds formed by structural modifications of the ATP molecule including substitutions of the purine ring (C2, C8, N1, and N(6)-substituents, and a uridine base instead of adenine), the ribose moiety (2' and 3'-positions), and the triphosphate group (lower phosphates, bridging oxygen substitution, and cyclization) were prepared. Pharmacological activity at P(2Y)-purinoceptors was assayed in the guinea pig taenia coli, endothelial cells of the rabbit aorta, smooth muscle of the rabbit mesenteric artery, and turkey erythrocyte membranes. Activity at P(2X)-purinoceptors was assayed in the rabbit saphenous artery and the guinea-pig vas deferens and urinary bladder. Some of the analogues displayed selectivity, or even specificity, for either the P(2X)- or the P(2Y)-purinoceptors. Certain analogues displayed selectivity or specificity within the P(2X)- or P(2Y)-purinoceptor superfamilies, giving hints about possible subclasses. For example, 8-(6-aminohexylamino)ATP and 2',3'-isopropylidene-AMP were selective for endothelial Pzypurinoceptors over P(2Y)-purinoceptors in the guinea pig taenia coli, rabbit aorta, and turkey erythrocytes. These compounds were both inactive at P(2X)-purinoceptors. The potent agonist N(6)-methyl ATP and the somewhat less potent agonist 2'-deoxy-ATP were selective for P(2Y)-purinoceptors in the guinea pig taenia coli, but were inactive at P(2X)-purinoceptors and the vascular P(2Y)-purinoceptors. 3'-Benzylamino-3'-deoxyATP was very potent at the P(2X)-purinoceptors in the guinea pig vas deferens and bladder, but not in the rabbit saphenous artery and was inactive at P(2Y) receptors. These data suggest that specific compounds can be developed that can be utilized to activate putative subtypes of the P(2X)- and P(2Y)-purinoceptor classes.
研究了多种腺嘌呤核苷酸类似物在P(2x) - 和P(2Y) - 嘌呤受体上的构效关系。制备了通过ATP分子结构修饰形成的化合物,包括嘌呤环的取代(C2、C8、N1和N(6) - 取代基,以及用尿嘧啶碱基代替腺嘌呤)、核糖部分(2'和3' - 位)和三磷酸基团(低级磷酸盐、桥连氧取代和环化)。在豚鼠结肠带、兔主动脉内皮细胞、兔肠系膜动脉平滑肌和火鸡红细胞膜中测定了对P(2Y) - 嘌呤受体的药理活性。在兔隐动脉、豚鼠输精管和膀胱中测定了对P(2X) - 嘌呤受体的活性。一些类似物对P(2X) - 或P(2Y) - 嘌呤受体表现出选择性,甚至特异性。某些类似物在P(2X) - 或P(2Y) - 嘌呤受体超家族内表现出选择性或特异性,提示可能存在亚类。例如,8 - (6 - 氨基己基氨基)ATP和2',3' - 异亚丙基 - AMP在豚鼠结肠带、兔主动脉和火鸡红细胞中对内皮P2y嘌呤受体比对P(2Y) - 嘌呤受体具有选择性。这些化合物在P(2X) - 嘌呤受体上均无活性。强效激动剂N(6) - 甲基ATP和效力稍弱的激动剂2' - 脱氧 - ATP在豚鼠结肠带中对P(2Y) - 嘌呤受体具有选择性,但在P(2X) - 嘌呤受体和血管P(2Y) - 嘌呤受体上无活性。3' - 苄基氨基 - 3' - 脱氧ATP在豚鼠输精管和膀胱的P(2X) - 嘌呤受体上非常有效,但在兔隐动脉中无效,在P(2Y)受体上无活性。这些数据表明,可以开发出特定的化合物,用于激活P(2X) - 和P(2Y) - 嘌呤受体类别的假定亚型。